Columbia Partners Investment Management’s Quest Diagnostics DGX Stock Holding History

Columbia Partners Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,221	Closed	-$378K	–	348
2015 Q2	$378K	Buy	+5,221	New	+$385K	0.02%	304
2015 Q1	–	Sell	-14,787	Closed	-$991K	–	332
2014 Q4	$991K	Buy	+14,787	New	+$933K	0.05%	275
2014 Q2	–	Sell	-8,632	Closed	-$499K	–	344
2014 Q1	$499K	Sell	8,632 -1,722	-17%	-$92.3K	0.02%	316
2013 Q4	$554K	Sell	10,354 -2,544	-20%	-$151K	0.02%	305
2013 Q3	$796K	Sell	12,898 -15,778	-55%	-$944K	0.04%	298
2013 Q2	$1.74M	Buy	+28,676	New	+$1.71M	0.08%	221

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Columbia Partners Investment Management's DGX Position: Q3 2015 in Review

Columbia Partners Investment Management sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 5,221 shares — an estimated $378K sold.

Columbia Partners Investment Management first reported a position in DGX in Q2 2013 and held it in 6 quarters. The position peaked at $1.74M in Q2 2013. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

Columbia Partners Investment Management reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
Columbia Partners Investment Management sold 5,221 Quest Diagnostics shares in Q3 2015, an estimated $378K.
Columbia Partners Investment Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 6 quarters.
Columbia Partners Investment Management's Quest Diagnostics position peaked at $1.74M in Q2 2013.
540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Columbia Partners Investment Management's 13F filing for Q3 2015, filed 10 Nov 2015.